markets

J. Edward Moreno

2/19/25

Hims & Hers to provide at-home blood testing with new acquisition

Hims & Hers’ share price shot up more than 15% after the company announced it had acquired at-home lab testing facility Trybe Labs.

Hims & Hers, an online pharmacy best known for selling knock-off versions of weight-loss drugs made by Novo Nordisk, will now be able to support at-home blood draws to test “hormone levels, cardiac risk, stress markers, cholesterol, liver function, thyroid function, and prostate health,” the company said in a statement.

Trybe Labs sends customers a packet that includes a blood lancet, similar to those used by diabetics. Consumers then ship the samples back and wait for results.

Hims & Hers didn’t disclose how much it paid to buy Trybe Labs. The company has been on a spending spree recently: it bought an ad for the Super Bowl this month, which sparked pushback from Novo Nordisk and lawmakers, who said it made false or misleading statements about the safety and efficacy of compounded drugs.

Hims & Hers said it will use de-identified blood-testing data to develop a proprietary AI-powered system that gives patients “personalized care.”

Hims & Hers acquires at-home lab testing facility, expanding capabilities to ultimately include affordable whole body testing for subscribers

Hims & Hers acquires at-home lab testing facility, expanding capabilities to ultimately include affordable whole body testing for subscribers

Trybe Labs sends customers a packet that includes a blood lancet, similar to those used by diabetics. Consumers then ship the samples back and wait for results.

Hims & Hers didn’t disclose how much it paid to buy Trybe Labs. The company has been on a spending spree recently: it bought an ad for the Super Bowl this month, which sparked pushback from Novo Nordisk and lawmakers, who said it made false or misleading statements about the safety and efficacy of compounded drugs.

Hims & Hers said it will use de-identified blood-testing data to develop a proprietary AI-powered system that gives patients “personalized care.”

More Markets

See all Markets

Electricity inflation hits highest level in two years as AI boom rumbles on

Is your power bill going to kill the AI trade?

AI data center electricity

Nia Warfield, Luke Kawa

S&P 500, Nasdaq 100 post record closing highs as nearly everything rallies

The benchmark US stock index ended up 0.9%, the Nasdaq 100 rose 0.6%, and the Russell 2000 outperformed with a 1.8% gain.

Bull charging across sand creating dust cloud

markets

15h

Warner Bros. Discovery jumps after Wells Fargo ups price target on dealmaking buzz

Warner Bros. Discovery shares popped 7% Tuesday after Wells Fargo raised its price target on the media giant to $14 from $13 while keeping an equal-weight rating.

The bank’s optimism stemmed largely from the media giant’s potential for dealmaking. In June, WBD announced that it would split its operations into two companies, with the Streaming & Studios division (home to Warner Bros. Television, DC Studios, HBO, and Max) standing alone from the networks side (CNN, TNT Sports, and Discovery).

That separation could make the Streaming & Studios unit more attractive to buyers, the analysts said. They valued the segment at about $65 billion, which could translate to a takeover price north of $21 a share. Potential suitors range from Amazon and Apple to Sony and Comcast, though analysts flagged Netflix as the “most compelling” option despite its limited acquisition track record:

“While NFLX has historically not been acquisitive, [streaming and studios’] $12bn in annual content spend + library + 100+ acre studio lot offers a lot. It kickstarts a theatrical IP strategy, quickly scales video games and most importantly provides premium content to members.”

At Goldman Sachs’ Communacopia + Technology Conference this week, CEO David Zaslav also highlighted growing traction at HBO Max and hinted at future crackdowns on password sharing.

WBD shares are up 26% year to date, and up more than 93% over the past 12 months.

markets

15h

Duolingo up on bullish note, hopes for a user rebound

Duolingo rose by the most in nearly a month after an analyst note painted a more bullish picture of the gamified language-learning company despite a dearth of news otherwise.

A quick check-in with analysts covering the stock on Wall Street found most of them otherwise flummoxed on the reason behind the uptick Thursday.

Some, however, suggested the rise may reflect optimism that the company has been able to reverse a monthslong downturn in daily active user metrics — a slump that set in after a social media backlash to a somewhat artless LinkedIn post from the company about its AI first strategy.

The bullish analyst note, published Thursday by Citizens JMP, suggested Duolingo could be a big beneficiary from a change to Apple’s rules governing its App Store driven by a ruling on a federal antitrust case against the company. The analysts wrote:

Given “Apple’s recent changes to U.S. App Store rules that allow developers to steer payments to the web where fees are similar to typical credit card fees rather than Apple’s 30% fee for in-app purchases and 30% fee on subscriptions for the first year and 15% thereafter, we expect mobile app companies including Duolingo, Life360, and Grindr Inc. to unlock meaningful cost benefits.”

At any rate, the next big event on the company’s calendar is its Duocon 2025 conference on Tuesday, where analysts are hoping to hear more hard information on all of the above topics.

markets

15h

Jeep maker Stellantis surges as CEO says the automaker is in productive tariff talks with the US

Shares of Jeep and Dodge maker Stellantis are up more than 8% in Thursday afternoon trading, following comments from the automaker’s new CEO, Antonio Filosa, at a European auto conference.

On tariffs, Filosa said that Stellantis has had a “very productive exchange of ideas” with the Trump administration on the company’s manufacturing footprint and that the environment around the levies is “getting clearer and clearer.”

The US is Stellantis’ top priority, according to Filosa, and the company has taken efforts to turn things around in the market, where it’s struggled with sales in recent years. To fuel the turnaround, Stellantis is bringing back its popular Jeep Cherokee, which it discontinued in 2023.

As of 12:45 p.m. ET, Stellantis’ trading volume was at more than 140% of its average over the past 30 days.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.

©2025 Sherwood Media, LLC